
Mizar Therapeutics provides a platform that speeds drug discovery by imaging live cells and analyzing data with machine learning. The core tech combines live-cell super-resolution imaging, single-molecule tracking, and AI-powered data extraction to identify condensate modulators and novel cancer therapies. The company operates in biotechnology as a platform therapeutics company focusing on oncology and partnerships with pharma. By delivering high-frequency, long-duration imaging and data-driven insights, it aims to scale hit discovery, lead optimization, and target identification.

Mizar Therapeutics provides a platform that speeds drug discovery by imaging live cells and analyzing data with machine learning. The core tech combines live-cell super-resolution imaging, single-molecule tracking, and AI-powered data extraction to identify condensate modulators and novel cancer therapies. The company operates in biotechnology as a platform therapeutics company focusing on oncology and partnerships with pharma. By delivering high-frequency, long-duration imaging and data-driven insights, it aims to scale hit discovery, lead optimization, and target identification.